Conference Description:

The HPAPI Summit brings together perspectives throughout the value chain from bench to outsource, providing you with a unified outlook on the latest developments in highly potent manufacturing.

As compounds become increasingly potent, the need for harmonization among distinct groups within organizations around key challenges is more acute than ever before.

By involving multiple perspectives from companies of different size and experience in the field, the HPAPI Summit will enable you to understand how you can implement safe and robust practices in your own organization.

Incorporating insights from Genentech, Pfizer, Vertex, SafeBridge and Boehringer Ingelheim, you will leave this conference with actionable insights that will enable you to produce highly potent APIs more robustly, safely and cost-effectively.

Group booking discounts and start-up biotech rates are available upon request. Email [email protected] to enquire about your eligibility.

URLs:
Brochure: https://go.evvnt.com/204863-1?pid=154
Booking: https://go.evvnt.com/204863-2?pid=154

Time: 08:00 to 18:00

Price:
Conference + 3 Workshops: USD 4596,
Conference + 2 Workshops: USD 3997,
Conference + 1 Workshops: USD 3398,
Conference Only: USD 2799

Speakers: Marc Abromovitz (Novartis), Richard Wooster (Tarveda Therapeutics), Reinhold Maeck (Boehringer Ingelheim), Paul Richards (Biogen), Jacqui Van Sipe (Vertex), Samuel Baron (SK Biotech Ireland), Jay Brown (Alkermes), Dean Calhoun (Affygility Solutions), Scott Duncan (Stealth Biotherapeutics), Timothy Maher (Merck), Evan Thackaberry (Ra Pharmaceuticals), John Roosa (Merck) and Many More!